Sitagliptin treatment in patients with type 2 diabetes mellitus after kidney transplant.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Sitagliptin (Primary) ; Sirolimus; Tacrolimus
- Indications Renal transplant rejection; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2010 Planned end date changed from 1 Dec 2008 to 1 Mar 2010 as reported by ClinicalTrials.gov.